Morgan Stanley’s Hoth Therapeutics HOTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7K | Hold |
10,006
| – | – | ﹤0.01% | 6811 |
|
|
2025
Q1 | $10K | Hold |
10,006
| – | – | ﹤0.01% | 6795 |
|
|
2024
Q4 | $7.49K | Sell |
10,006
-314
| -3% | -$235 | ﹤0.01% | 6897 |
|
|
2024
Q3 | $9.08K | Buy |
10,320
+312
| +3% | +$275 | ﹤0.01% | 6744 |
|
|
2024
Q2 | $9.1K | Hold |
10,008
| – | – | ﹤0.01% | 6709 |
|
|
2024
Q1 | $15.2K | Buy |
10,008
+9,996
| +83,300% | +$15.2K | ﹤0.01% | 6566 |
|
|
2023
Q4 | $16 | Buy |
12
+6
| +100% | +$8 | ﹤0.01% | 7765 |
|
|
2023
Q3 | $10 | Hold |
6
| – | – | ﹤0.01% | 7560 |
|
|
2023
Q2 | $18 | Buy |
6
+5
| +500% | +$15 | ﹤0.01% | 7588 |
|
|
2023
Q1 | $2 | Sell |
1
-1
| -50% | -$2 | ﹤0.01% | 7696 |
|
|
2022
Q4 | $16 | Buy |
+2
| New | +$16 | ﹤0.01% | 7786 |
|
|
2022
Q3 | – | Sell |
-204
| Closed | -$2K | – | 7774 |
|
|
2022
Q2 | $2K | Sell |
204
-5
| -2% | -$49 | ﹤0.01% | 7587 |
|
|
2022
Q1 | $4K | Buy |
209
+205
| +5,125% | +$3.92K | ﹤0.01% | 7633 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 8024 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 7970 |
|
|
2021
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 7764 |
|
|
2021
Q1 | $0 | Sell |
4
-136
| -97% | – | ﹤0.01% | 7516 |
|
|
2020
Q4 | $8K | Buy |
+140
| New | +$8K | ﹤0.01% | 6689 |
|
|
2020
Q2 | – | Sell |
-1
| Closed | – | – | 6649 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6619 |
|
|
2019
Q4 | $0 | Sell |
1
-11
| -92% | – | ﹤0.01% | 6690 |
|
|
2019
Q3 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 6544 |
|